Azitra and Jackson Labs Receive Department of Defense Grant for Next-Generation Anti-Infectives

Azitra Awarded NIH SBIR Grant to Develop Microbiome-based Therapeutic for Netherton Syndrome

Cosmetics & Toiletries

“The Microbiome Movement: Commensal Cosmetics Offer a Viable Future”

Azitra Secures $2.15 Million Convertible Debt Financing Led Jointly by Bios Partners and Connecticut Innovations

Azitra to Present at the Biotech Showcase™ Annual Conference on January 8, 2018

Azitra Founder Travis Whitfill, MPH named Forbes “30 under 30 in Healthcare”

Richard Andrews Appointed CEO

Richard Andrews joins Azitra as President and CEO to lead company’s transition through development and into the clinic.

Julia Oh, Ph.D., Multi-Award winner

Julia Oh, member of Azitra’s Scientific Advisory Board, received NIH New Innovator Award for skin microbiome research

October 9, 2017
Julia Oh, recognized by Business Insider as one of 30 Young Leaders in BioPharma

Azitra Raises $3.75 Million

Azitra closes a $2.9 million Series A venture round bringing total funding raised to $3.75 million